Stryker Corporation (SYK)
NYSE · Healthcare · Medical - Devices
Profile
Stryker Corporation
- Exchange
- NYSE
- Ticker
- SYK
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- US
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
Key facts
Stryker Corporation: key facts
- Stryker Corporation (NYSE: SYK) is a Medical - Devices company in the Healthcare sector.
- In fiscal 2025, Stryker Corporation reported revenue of $25.1B and net income of $3.2B.
- Revenue grew 10.1% a year over the last 4 fiscal years.
- Free cash flow was positive in 5 of the last 5 fiscal years.
- Net income was positive in 5 of the last 5 fiscal years.
- Over the last twelve months, revenue was $26.3B and net income was $3.6B.
MonkScore
Stryker Corporation's MonkScore
MonkScore
MonkScore range: 70–80
as of October 2026
Sector rank: 207 of 628 in Healthcare
How this score is madeDisclaimer
Pillar ranges
- Growth50–60
- Profitability70–80
- Quality30–40
- Market Conviction60–70
- Safety60–70
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
Stryker Corporation's annual figures and the last twelve months, in USD. Last report: 30 September 2026.
| Figure | Last 12 months | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $26.3B | $25.1B | $22.6B | $20.5B | $18.4B | $17.1B |
| Gross profit | $17.2B | $16.1B | $14.5B | $12.5B | $11.0B | $10.7B |
| Operating income | $5.6B | $4.9B | $3.7B | $4.3B | $3.7B | $3.8B |
| Net income | $3.6B | $3.2B | $3.0B | $3.2B | $2.4B | $2.0B |
| Operating cash flow | $5.4B | $5.0B | $4.2B | $3.7B | $2.6B | $3.3B |
| Capital expenditure | -$873.0M | -$761.0M | -$755.0M | -$575.0M | -$588.0M | -$525.0M |
| Free cash flow | $4.6B | $4.3B | $3.5B | $3.1B | $2.0B | $2.7B |
| Total debt | $14.2B | $16.4B | $14.1B | $13.5B | $13.5B | $12.9B |
| Cash | $3.3B | $4.0B | $3.7B | $3.0B | $1.8B | $2.9B |
Revenue growth a year
- 1-year
- 11.2%
- 3-year
- 10.8%
- 4-year
- 10.1%
Compound growth between fiscal years.
Peers
Similar companies
- Inspire Medical Systems, Inc.NYSE:INSPMonkScore range: 70–80
- Globus Medical, Inc.NYSE:GMEDMonkScore range: 70–80
- UFP Technologies, Inc.NASDAQ:UFPTMonkScore range: 70–80
- AxoGen, Inc.NASDAQ:AXGNMonkScore range: 70–80
- iRhythm Technologies, Inc.NASDAQ:IRTCMonkScore range: 80–90
- NeuroPace, Inc.NASDAQ:NPCEMonkScore range: 80–90
- Haemonetics CorporationNYSE:HAEMonkScore range: 80–90
- Cerus CorporationNASDAQ:CERSMonkScore range: 80–90
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 31 October 2026.